Vasculitis classification
|
Vasculitis |
|
|---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: M.Umer Tariq [2]
Overview
Classification
Vasculitides can be classified by the size of the blood vessel that they predominantly affect.[1][2]
| Examples | |||
|---|---|---|---|
| Large vessel[3] Associated with Type IV, cellular (delayed), hypersensitivity. |
Takayasu arteritis. Primarily affects the aorta and its main branches. Patients are usually less than 50 years old. May be associated with anti-endothelial cell antibody.
Giant cell (temporal) arteritis. Chronic vasculitis of both large and medium vessels, primarily affecting cranial branches of the arteries arising from the aortic arch. Patients are usually over 50 years old. |
||
| Medium vessel[3] Dermatological findings include:[5]
|
Polyarteritis nodosa. Systemic necrotizing vasculitis and aneurysm formation with sparing of the lungs and glomeruli. Blood tests for autoimmunity are usually normal; however, tests for inflammation (such as the erythrocyte sedimentation rate) may be abnormal.
Kawasaki disease. Affects vessels of all sizes especially the coronary arteries. Usually in children and is associated with a mucocutaneous lymph node syndrome. Thromboangiitis obliterans (Buerger's disease). Blood tests for inflammation (including the erythrocyte sedimentation rate) and autoimmunity are usually normal. Isolated central nervous system vasculitis. Affects medium and small arteries over a diffuse CNS area, without symptomatic extracranial vessel involvement. Patients have CNS symptoms as well as cerebral vasculitis by angiography and leptomeningeal biopsy. |
||
| Small vessel[2] Associated with Type III, immediate hypersensitivity.
|
ANCA Antineutrophil cytoplasmic antibodies (ANCA) are associated with some small vessel vasculitides including their localized forms such as pauci-immune necrotising and crescentic glomerulonephritis.[7] With partial exception from microscopic polyangiitis, these vasculitides are associated with respiratory manifestations.[2][7] |
Granulomatous polyangiitis (Wegener's granulomatosis). Systemic vasculitis of medium and small arteries, including venules and arterioles. Produces granulomatous inflammation of the respiratory tracts and necrotizing, pauci-immune glomerulonephritis. Most common cause of saddle nose deformity in USA (nose flattened due to destruction of nasal septum by granulomatous inflammation). Almost all patients with Wegener's have c-ANCA, but not vice versa.
Churg-Strauss arteritis. Affects medium and small vessels with vascular and extravascular granulomatosis. Classically involves arteries of lungs and skin, but may be generalized. The triad asthma, eczema and renal abnormalities (e.g., red blood cell casts in urine) should raise suspicion, calling for an eosinophil count. Eosinophilia, with this clinical presentation, is grounds for a preliminary diagnosis, but immunologic confirmation is needed. Microscopic polyarteritis/polyangiitis. Affects capillaries, venules, or arterioles. Thought to be part of a group that includes granulomatous polyangiitis since both are associated with ANCA and similar extrapulmonary manifestations. Patients do not usually have symptomatic or histologic respiratory involvement.[7] |
Treatment depends on whether the goal is to induce remission or maintenance and depends on severity of the vasculitis.[8] |
| Immune complex These vasculitides are associated with immune complexes. With partial exception from microscopic polyangiitis, are associated with dermatological manifestations.[2] With the exception of Henoch-Schonlein purpura, serum levels of complement system proteins may be low in these vasculitides. |
Henoch-Schonlein purpura (HSP). Systemic vasculitis due to tissue deposition of IgA-containing immune complexes. This is the most common vasculitis in children.
Hypocomplementemic urticarial vasculitis[5] Essential cryoglobulinemic vasculitis. Most often due to hepatitis C infection, immune complexes of cryoglobulins. |
||
| Variable-vessel vasculitis (VVV) ... |
Behçet disease. | ||
| Single-organ vasculitis (SOV) ... |
Cutaneous leukocytoclastic angiitisUsually due to a hypersensitivity reaction to a known drug.[9] There is presence of skin vaculitis termed leukocytoclastic vasculitis with palpable petechiae or purpura. Most prominent in postcapillary venules. |
||
| Vasculitis associated with systemic disease ... |
Connective tissue diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), sarcoidosis, and others. |
||
| Vasculitis associated with probable etiology ... |
Vasculitis secondary to viral infection. Usually due to hepatitis B virus and hepatitis C virus, Human Immunodeficiency Virus Type 1 (HIV), cytomegalovirus, Epstein Barr virus, and Parvovirus B19. Syphilis-associated aortitis Drug-associated immune complex vasculitis Drug-associated ANCA-associated vasculitis Cancer-associated vasculitis |
||
References
- ↑ Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F; et al. (2013). "2012 revised international chapel hill consensus conference nomenclature of vasculitides". Arthritis Rheum. 65 (1): 1–11. doi:10.1002/art.37715. PMID 23045170.
- ↑ 2.0 2.1 2.2 2.3 2.4 Jennette JC, Falk RJ (1997). "Small-vessel vasculitis". N. Engl. J. Med. 337 (21): 1512–23. PMID 9366584.
- ↑ 3.0 3.1 3.2 Weyand CM, Goronzy JJ (2003). "Medium- and large-vessel vasculitis". N. Engl. J. Med. 349 (2): 160–9. doi:10.1056/NEJMra022694. PMID 12853590.
- ↑ Rabb H, Colvin RB (2007). "Case records of the Massachusetts General Hospital. Case 31-2007. A 41-year-old man with abdominal pain and elevated serum creatinine". N. Engl. J. Med. 357 (15): 1531–41. doi:10.1056/NEJMcpc079024. PMID 17928602.
- ↑ 5.0 5.1 5.2 Kroshinsky D, Stone JH, Nazarian RM (2011). "Case records of the Massachusetts General Hospital. Case 22-2011. A 79-year-old man with a rash, arthritis, and ocular erythema". N Engl J Med. 365 (3): 252–62. doi:10.1056/NEJMcpc1100929. PMID 21774714.
- ↑ Chen KR, Carlson JA (2008). "Clinical approach to cutaneous vasculitis". Am J Clin Dermatol. 9 (2): 71–92. PMID 18284262.
- ↑ 7.0 7.1 7.2 Bosch X, Guilabert A, Font J (2006). "Antineutrophil cytoplasmic antibodies". Lancet. 368 (9533): 404–18. doi:10.1016/S0140-6736(06)69114-9. PMID 16876669.
- ↑ Bosch X, Guilabert A, Espinosa G, Mirapeix E (2007). "Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review". JAMA. 298 (6): 655–69. doi:10.1001/jama.298.6.655. PMID 17684188.
- ↑ ten Holder SM, Joy MS, Falk RJ (2002). "Cutaneous and systemic manifestations of drug-induced vasculitis". Ann Pharmacother. 36 (1): 130–47. PMID 11816242.